Financhill
Buy
51

BP Quote, Financials, Valuation and Earnings

Last price:
$28.60
Seasonality move :
1.59%
Day range:
$28.14 - $28.74
52-week range:
$27.82 - $40.40
Dividend yield:
6.41%
P/E ratio:
30.07x
P/S ratio:
0.41x
P/B ratio:
1.16x
Volume:
10.1M
Avg. volume:
10.7M
1-year change:
-18.33%
Market cap:
$75.5B
Revenue:
$210.1B
EPS (TTM):
$0.95
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $159.3B $105.9B $157.7B $241.4B $210.1B
Revenue Growth (YoY) -46.68% -33.5% 48.89% 53.03% -12.95%
 
Cost of Revenues $131.7B $95.8B $134.9B $186.3B $162.1B
Gross Profit $27.6B $10.2B $22.9B $55.1B $48.1B
Gross Profit Margin 17.31% 9.61% 14.49% 22.82% 22.88%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11.1B $10.4B $11.9B $13.4B $16.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $11.4B $10.8B $12.2B $13.6B $17B
Operating Income $16.2B -$573M $10.7B $41.4B $31B
 
Net Interest Expenses $2.8B $2.4B $2.1B $1.5B $1.9B
EBT. Incl. Unusual Items $8.2B -$24.9B $15.2B $15.4B $23.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4B -$4.2B $6.7B $16.8B $7.9B
Net Income to Company $8.2B -$24.9B $15.2B $15.4B $23.7B
 
Minority Interest in Earnings -$164M $424M -$922M -$1.1B -$641M
Net Income to Common Excl Extra Items $4B -$20.3B $7.6B -$2.5B $15.2B
 
Basic EPS (Cont. Ops) $1.19 -$6.03 $2.25 -$0.79 $5.27
Diluted EPS (Cont. Ops) $1.18 -$6.03 $2.24 -$0.79 $5.15
Weighted Average Basic Share $3.4B $3.4B $3.4B $3.2B $2.9B
Weighted Average Diluted Share $3.4B $3.4B $3.4B $3.2B $3B
 
EBITDA $29.4B -$7B $32.5B $32.3B $43.5B
EBIT $11.6B -$21.9B $17.7B $18B $27.6B
 
Revenue (Reported) $159.3B $105.9B $157.7B $241.4B $210.1B
Operating Income (Reported) $16.2B -$573M $10.7B $41.4B $31B
Operating Income (Adjusted) $11.6B -$21.9B $17.7B $18B $27.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $26.3B $36.2B $55B $53.3B $47.3B
Revenue Growth (YoY) -61.47% 37.48% 52.07% -3.17% -11.29%
 
Cost of Revenues $22.4B $34.3B $51.3B $40.6B $39.7B
Gross Profit $3.9B $1.9B $3.7B $12.6B $7.5B
Gross Profit Margin 14.92% 5.29% 6.76% 23.72% 15.93%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.4B $3.1B $3.3B $4.5B $3.9B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.6B $3.2B $3.5B $4.6B $4.3B
Operating Income $1.3B -$1.3B $232M $8.1B $3.2B
 
Net Interest Expenses $625M $530M $474M $568M $621M
EBT. Incl. Unusual Items $150M -$495M $2B $7.3B $1.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $457M $1.9B $4B $2.2B $1B
Net Income to Company $150M -$495M $2B $7.3B $1.4B
 
Minority Interest in Earnings -$143M -$199M -$179M -$211M -$164M
Net Income to Common Excl Extra Items -$450M -$2.5B -$2.2B $4.9B $206M
 
Basic EPS (Cont. Ops) -$0.13 -$0.76 -$0.69 $1.69 $0.08
Diluted EPS (Cont. Ops) -$0.13 -$0.76 -$0.69 $1.66 $0.07
Weighted Average Basic Share $3.4B $3.4B $3.1B $2.9B $2.7B
Weighted Average Diluted Share $3.4B $3.4B $3.1B $2.9B $2.8B
 
EBITDA $4.5B $4.2B $6.3B $12.5B $6.6B
EBIT $950M $198M $2.6B $8.3B $2.5B
 
Revenue (Reported) $26.3B $36.2B $55B $53.3B $47.3B
Operating Income (Reported) $1.3B -$1.3B $232M $8.1B $3.2B
Operating Income (Adjusted) $950M $198M $2.6B $8.3B $2.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $149.7B $134.6B $222.7B $227.2B $195.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $134.7B $117.3B $183.8B $166B $160.3B
Gross Profit $15B $17.3B $38.9B $61.3B $35.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $10.6B $11.3B $13.2B $15.7B $17.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $21B $2B $13.5B $15.9B $17.6B
Operating Income -$6B $15.3B $25.3B $45.3B $17.7B
 
Net Interest Expenses $2.7B $2.2B $1.6B $1.8B $2.4B
EBT. Incl. Unusual Items -$25.7B $12.3B $2.5B $39.6B $8.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.5B $4.9B $12.5B $12.9B $5.1B
Net Income to Company -$25.7B $12.3B $2.5B $39.6B $8.4B
 
Minority Interest in Earnings $552M -$797M -$1B -$934M -$574M
Net Income to Common Excl Extra Items -$21.6B $6.6B -$11B $25.7B $2.7B
 
Basic EPS (Cont. Ops) -$6.42 $1.95 -$3.39 $8.63 $0.98
Diluted EPS (Cont. Ops) -$6.42 $1.93 -$3.42 $8.46 $0.95
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3.3B $26.1B $19.5B $58.4B $29.4B
EBIT -$22.5B $15B $4.8B $43.1B $12.8B
 
Revenue (Reported) $149.7B $134.6B $222.7B $227.2B $195.6B
Operating Income (Reported) -$6B $15.3B $25.3B $45.3B $17.7B
Operating Income (Adjusted) -$22.5B $15B $4.8B $43.1B $12.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $78.5B $107.2B $172.1B $158B $143.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $70.6B $92.1B $141.1B $120.7B $119B
Gross Profit $8B $15.1B $31.1B $37.2B $24.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.6B $8.6B $9.8B $12B $12.3B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $17.7B $8.9B $10.2B $12.5B $13.1B
Operating Income -$9.7B $6.2B $20.8B $24.7B $11.3B
 
Net Interest Expenses $2B $1.8B $1.3B $1.6B $2B
EBT. Incl. Unusual Items -$26B $11.2B -$1.5B $22.7B $7.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.8B $5.3B $11B $7.2B $4.4B
Net Income to Company -$26B $11.2B -$1.5B $22.7B $7.3B
 
Minority Interest in Earnings $551M -$670M -$772M -$576M -$509M
Net Income to Common Excl Extra Items -$21.7B $5.2B -$13.3B $14.9B $2.3B
 
Basic EPS (Cont. Ops) -$6.43 $1.54 -$4.09 $5.06 $0.84
Diluted EPS (Cont. Ops) -$6.43 $1.53 -$4.12 $4.96 $0.82
Weighted Average Basic Share $10.1B $10.1B $9.6B $8.8B $8.3B
Weighted Average Diluted Share $10.1B $10.1B $9.7B $9B $8.4B
 
EBITDA -$2.4B $24.3B $11.3B $37.4B $23.2B
EBIT -$23.6B $13.3B $372M $25.5B $10.7B
 
Revenue (Reported) $78.5B $107.2B $172.1B $158B $143.4B
Operating Income (Reported) -$9.7B $6.2B $20.8B $24.7B $11.3B
Operating Income (Adjusted) -$23.6B $13.3B $372M $25.5B $10.7B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $20.8B $29.2B $25.9B $23.3B $27.7B
Short Term Investments $169M $333M $280M $578M $843M
Accounts Receivable, Net $19.4B $12.9B $22.3B $28.2B $25.2B
Inventory $20.9B $16.9B $23.7B $28.1B $22.8B
Prepaid Expenses $857M $1.3B $2.5B $2.1B $2.5B
Other Current Assets -- -- -- -- --
Total Current Assets $82.1B $73B $92.6B $107.7B $104.1B
 
Property Plant And Equipment $146.7B $118.9B $117.2B $110.3B $109B
Long-Term Investments -- -- -- -- --
Goodwill $11.9B $12.5B $12.4B $12B $12.5B
Other Intangibles $1.4B $2B $2.2B $6B $5.7B
Other Long-Term Assets -- -- -- -- --
Total Assets $295.2B $267.7B $287.3B $288.1B $280.3B
 
Accounts Payable $30.5B $23.2B $37.3B $47.2B $42.4B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $2.1B $1.9B $1.7B $2.1B $2.7B
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $73.6B $59.8B $80.3B $99B $86.1B
 
Long-Term Debt $57.2B $63.3B $55.6B $43.7B $48.7B
Capital Leases -- -- -- -- --
Total Liabilities $194.5B $182.1B $196.8B $205.1B $194.8B
 
Common Stock $5.4B $5.4B $5.2B $4.8B $4.5B
Other Common Equity Adj -- -- -- -- --
Common Equity $98.4B $71.2B $75.4B $67.5B $70.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.3B $14.3B $15B $15.4B $15.2B
Total Equity $100.7B $85.6B $90.4B $83B $85.5B
 
Total Liabilities and Equity $295.2B $267.7B $287.3B $288.1B $280.3B
Cash and Short Terms $21B $29.5B $26.2B $23.9B $28.6B
Total Debt $67.7B $72.7B $61.2B $46.9B $52B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $30.7B $30.7B $29.3B $29.9B $34.6B
Short Term Investments $298M $191M $300M $932M $167M
Accounts Receivable, Net $16B $25.3B $34.8B $31.6B $26.1B
Inventory $13.8B $25.2B $29.5B $25.7B $21.5B
Prepaid Expenses $645M $1.5B $1.1B $1.3B $1.1B
Other Current Assets -- -- -- -- --
Total Current Assets $70.8B $90.5B $108.4B $103.4B $93.7B
 
Property Plant And Equipment $116.6B $114.5B $105B $107.2B $99.6B
Long-Term Investments -- -- -- -- --
Goodwill $12.5B $12.4B $11.1B $12.3B $12.9B
Other Intangibles $6.3B $6.3B $6.3B $10B $10.6B
Other Long-Term Assets -- -- -- -- --
Total Assets $260.3B $286.5B $283.5B $280.2B $269.7B
 
Accounts Payable $33.8B $49.4B $56.3B $60.4B $54.4B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.9B $1.8B $1.8B $2.5B $2.7B
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $58.1B $78.1B $104.1B $85.6B $77B
 
Long-Term Debt $61.8B $59.5B $42.7B $45.9B $53B
Capital Leases -- -- -- -- --
Total Liabilities $178.1B $197.3B $210.1B $192.6B $189.8B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $14.2B $14.8B $15.2B $15.3B $15.1B
Total Equity $82.2B $89.3B $73.3B $87.7B $79.9B
 
Total Liabilities and Equity $260.3B $286.5B $283.5B $280.2B $269.7B
Cash and Short Terms $31B $30.9B $29.6B $30.9B $34.8B
Total Debt $72.8B $63.2B $46.6B $48.8B $57.5B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $8.2B -$24.9B $15.2B $15.4B $23.7B
Depreciation & Amoritzation $17.8B $14.9B $14.8B $14.3B $15.9B
Stock-Based Compensation $730M $723M $627M $795M $616M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$3.4B $4B -$7.5B -$5.5B $5.6B
Cash From Operations $25.8B $12.2B $23.6B $40.9B $32B
 
Capital Expenditures $15.4B $12.3B $10.9B $12.1B $14.3B
Cash Acquisitions -$2.3B $3.2B $3.9B -$2.4B -$775M
Cash From Investing -$17B -$7.9B -$5.7B -$13.7B -$14.9B
 
Dividends Paid (Ex Special Dividend) -$6.9B -$6.3B -$4.3B -$4.4B -$4.8B
Special Dividend Paid
Long-Term Debt Issued $8.6B $14.7B $7B $2B $7.6B
Long-Term Debt Repaid -$7.1B -$12.2B -$16.8B -$11.7B -$3.9B
Repurchase of Common Stock -$1.5B -$776M -$3.2B -$10B -$7.9B
Other Financing Activities $566M $12.4B $509M -$336M -$474M
Cash From Financing -$8.8B $4B -$18.1B -$28B -$13.4B
 
Beginning Cash (CF) $22.5B $22.5B $31.1B $30.7B $29.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$21M $8.3B -$161M -$802M $3.8B
Ending Cash (CF) $22.5B $31.1B $30.7B $29.2B $33B
 
Levered Free Cash Flow $10.4B -$144M $12.7B $28.9B $17.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $150M -$495M $2B $7.3B $1.4B
Depreciation & Amoritzation $3.5B $4B $3.7B $4.1B $4.1B
Stock-Based Compensation $199M $219M $251M $298M $278M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $5.2B $6B $8.3B $8.7B $6.8B
 
Capital Expenditures $2.6B $2.6B $3.1B $3.5B $4.2B
Cash Acquisitions -$975M $76M $505M -$68M -$45M
Cash From Investing -$3.5B -$2.6B -$2.6B -$3.5B -$4.2B
 
Dividends Paid (Ex Special Dividend) -$1.1B -$1.1B -$1.1B -$1.2B -$1.3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.6B $2.4B $1M $8M $2.4B
Long-Term Debt Repaid -$4.3B -$6.7B -$4B -$264M -$956M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $456M $244M $15M $299M -$278M
Cash From Financing -$5.6B -$6.8B -$9.2B -$4.2B -$3B
 
Beginning Cash (CF) $34.7B $34.3B $33.1B $28.9B $34.9B
Foreign Exchange Rate Adjustment $268M -$177M -$322M -$104M $179M
Additions / Reductions -$3.9B -$3.4B -$3.5B $1.1B -$475M
Ending Cash (CF) $31.1B $30.7B $29.3B $29.9B $34.6B
 
Levered Free Cash Flow $2.6B $3.3B $5.2B $5.3B $2.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$25.7B $12.3B $2.5B $39.6B $8.4B
Depreciation & Amoritzation $25.2B $4.7B $14.7B $15.3B $16.4B
Stock-Based Compensation $711M $580M $855M $685M $1B
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $17.5B $19.8B $33.5B $36.2B $29.2B
 
Capital Expenditures $13.3B $11B $11.1B $13.7B $15.7B
Cash Acquisitions $864M $6B $1.6B -$3.7B -$462M
Cash From Investing -$11.7B -$3.8B -$8.3B -$17.2B -$15.9B
 
Dividends Paid (Ex Special Dividend) -$7.4B -$4.3B -$4.3B -$4.7B -$4.9B
Special Dividend Paid
Long-Term Debt Issued $14B $9B $2.7B $6.1B $8.9B
Long-Term Debt Repaid -$9.3B -$17B -$12.5B -$6.1B -$2.3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $643M -$188M -$397M -$521M
Cash From Financing $5.4B -$16.5B -$25.7B -$18.4B -$8.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $11.2B -$496M -$471M $563M $4.6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $4.2B $8.7B $22.3B $22.5B $13.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$26B $11.2B -$1.5B $22.7B $7.3B
Depreciation & Amoritzation $21.2B $11.1B $10.9B $11.9B $12.4B
Stock-Based Compensation $544M $401M $629M $519M $946M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $9.9B $17.5B $27.4B $22.7B $19.9B
 
Capital Expenditures $9.4B $8.1B $8.4B $10B $11.4B
Cash Acquisitions $245M $3B $666M -$580M -$267M
Cash From Investing -$8.4B -$4.4B -$7B -$10.5B -$11.5B
 
Dividends Paid (Ex Special Dividend) -$5.3B -$3.2B -$3.3B -$3.6B -$3.7B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $12.1B $6.3B $2B $6B $7.4B
Long-Term Debt Repaid -$9B -$13.8B -$9.5B -$3.9B -$2.3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $12.3B $532M -$165M -$226M -$273M
Cash From Financing $7.1B -$13.3B -$20.9B -$11.3B -$6.7B
 
Beginning Cash (CF) $75.3B $97B $98.2B $88.5B $99.4B
Foreign Exchange Rate Adjustment $43M -$211M -$861M -$118M -$92M
Additions / Reductions $8.6B -$206M -$516M $849M $1.7B
Ending Cash (CF) $83.9B $96.6B $96.8B $89.3B $101B
 
Levered Free Cash Flow $509M $9.4B $19B $12.6B $8.5B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock